Anteris Technologies Global (AVR) Stock: Buy, Sell, or Hold?
AVR - Anteris Technologies Global Corp. Common Stock
$7.74
0.13 (1.71%)
▲
5d:
+0.65%
30d:
-9.9%
90d:
-26.77%
HOLD
MODERATE Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 24, 2026 at $7.69 · last confirmed Sep 29, 2026
Strength: 5.5/10
Get Alerted When AVR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AVR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AVR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AVR is currently trading at $7.74, which is considered oversold relative to its 30-day fair value range of $7.86 to $8.78.
Technical Outlook: Technically, AVR is showing sideways momentum. Immediate support is located at $7.47, while resistance sits at $8.57.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $15.33 (+101.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AVR is showing sideways momentum. Immediate support is located at $7.47, while resistance sits at $8.57.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $15.33 (+101.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.86 -
$8.78
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 101.5% below Wall St target ($15.33)
- NEUTRAL: Bottoming setup forming (54/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$7.86 -
$8.78
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.68
(8.8%)
Support & Resistance Levels
Support Level
$7.47
Resistance Level
$8.57
Current Trend
Sideways
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.61
Wall Street Target
$15.33
(+101.5%)
Revenue Growth (YoY)
63.3%
Share & Embed Analysis
Last updated: October 02, 2026 12:14 PM ET
Data refreshes hourly during market hours. Next update: 1:14 PM
Data refreshes hourly during market hours. Next update: 1:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 69 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 58 HOLD |
